KLRA compared with WAY: revenue, margins and what each company keeps, and the suppliers and customers both name

KLRAKailera Therapeutics, Inc.

Mkt capRevenueRevenue

WAYWaystar Holding Corp.

Mkt capRevenueRevenue

Compare

KLRAKailera Therapeutics, Inc.

WAYWaystar Holding Corp.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

KLRAKailera Therapeutics, Inc.

12.18▼−5.33%· post 12.33· delayed

Mkt cap$1.3BRevenue—Revenue—

WAYWaystar Holding Corp.

28.15▲+0.53%· post 26.95· delayed

After hoursNov 2 '26delayed

Mkt cap$5.4BRevenue$326MQ3 FY26Revenue$1.1BFY25

Compare

After hoursNov 2 '26delayed

KLRAKailera Therapeutics, Inc.

WAYWaystar Holding Corp.

12.18▼−5.33%post 12.33delayed

Price

28.15▲+0.53%post 26.95delayed

$1.3B

Mkt cap

$5.4B

—

Revenue

$326MQ3 FY26

—

Revenue

$1.1BFY25

KLRA12.18▼−5.33%vsWAY28.15▲+0.53%After hoursNov 2 '26delayed

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

KLRA: latest quarter not drawable.Method ›

Price

rebased to 0%

KLRA, solidWAY, dashed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only KLRA 1

—Hengruiunlistedsupplier

Shared 0

No shared counterparties.

Only WAY 2

PNCPNC Bank, National Associationsupplier

—PNC Capital Marketsunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR